Cabeza Marisa, Mejía Karla, García Fernando, Heuze Ivonne, Morales Miguel, Rodríguez-Dorantes Mauricio
Departamento de Sistemas Biológicos y de Producción Agrícola y Animal, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico.
Laboratorio de Oncogenómica, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
Drug Dev Res. 2025 Apr;86(2):e70078. doi: 10.1002/ddr.70078.
Studies suggest that vegetarians and Asians have lower mortality rates from prostate cancer compared to men who follow a Western diet. β-sitosterol, a key compound of plant-based diets, has been found to induce significant changes in the ultrasonic structure of the prostatic adenomas, making it a promising candidate for further prostate cancer research. Consequently, we investigated the potential of β-sitosterol and the synthetic derivative 2 as potent inhibitors of androgen synthesis, a critical process for the growth and survival of prostate tumor LNCaP cells. Solubilized LNCaP microsomes were used as a source of SRD5A1 and AKR1C3 to monitor androgen synthesis from labeled androstenedione, both in the presence and absence of β-sitosterol or 2. Furthermore, the effect of these steroids on LNCaP viability was determined using the MTT method. Our findings revealed significant insights into the androgen synthesis pathways in LNCaP cells. The most efficient metabolic route for dihydrotestosterone formation was the conversion of androstenedione to 5α-androstanedione rather than from testosterone in LNCaP. This conclusion is supported by the Vmax values for 5α-androstanedione formation (271.05 ± 5.0 ng/mg protein/min) and the Vmax of testosterone formation (80.1 ± 8.0 ng/mg protein/min). Both β-sitosterol and 2 demonstrated substantial inhibitory effects of these enzymes for dihydrotestosterone formation and significantly reduced cell viability, highlighting their therapeutic potential. These findings enhance our understanding of the inhibitory effects of β-sitosterol and 2 on LNCaP cells and suggest their promising application in the treatment of prostate cancer.
研究表明,与遵循西方饮食的男性相比,素食者和亚洲人患前列腺癌的死亡率较低。β-谷甾醇是植物性饮食的关键成分,已被发现可引起前列腺腺瘤超声结构的显著变化,使其成为前列腺癌进一步研究的有希望的候选物。因此,我们研究了β-谷甾醇及其合成衍生物2作为雄激素合成有效抑制剂的潜力,雄激素合成是前列腺肿瘤LNCaP细胞生长和存活的关键过程。使用溶解的LNCaP微粒体作为SRD5A1和AKR1C3的来源,以监测在有和没有β-谷甾醇或2的情况下从标记的雄烯二酮合成雄激素。此外,使用MTT法测定这些类固醇对LNCaP活力的影响。我们的研究结果揭示了对LNCaP细胞中雄激素合成途径的重要见解。在LNCaP中,形成二氢睾酮最有效的代谢途径是将雄烯二酮转化为5α-雄烷二酮,而不是从睾酮转化而来。这一结论得到了5α-雄烷二酮形成的Vmax值(271.05±5.0 ng/mg蛋白质/分钟)和睾酮形成的Vmax值(80.1±8.0 ng/mg蛋白质/分钟)的支持。β-谷甾醇和2都对这些酶形成二氢睾酮具有显著的抑制作用,并显著降低细胞活力,突出了它们的治疗潜力。这些发现加深了我们对β-谷甾醇和2对LNCaP细胞抑制作用的理解,并表明它们在前列腺癌治疗中的应用前景广阔。